Wednesday 17 January 2018

Cost-Effectiveness of Primary Radiation Therapy Versus Radical Prostatectomy for Intermediate- to High-Risk Prostate Cancer

Cost-Effectiveness of Primary Radiation Therapy Versus Radical Prostatectomy for Intermediate- to High-Risk Prostate Cancer: To compare, using a cost-effectiveness analysis, the quality-adjusted life expectancy
(QALE) and cost between the 2 treatment options for intermediate- to high-risk prostate
cancer: (1) radiation (RT) with androgen deprivation therapy (ADT) or (2) radical
prostatectomy (RP) followed by adjuvant RT for patients with risk factors.